Jones Day, response
Seven women brought a suit against Jones Day claiming gender discrimination. The firm responded, denying those claims and even calling the women themselves "sexist."

Jones Day Law Firm Responds to Gender Discrimination Suit

Women lawyers filed a lawsuit in April against the Jones Day law firm, claiming gender discrimination and unequal pay. This week, Jones Day filed a 115-page response.

 

The complaint filed in April alleged a “fraternity culture” at the firm. The seven women who brought the suit said they were underpaid in comparison to male lawyers with similar responsibilities. They used the industry-standard compensation guide, the Cravath Scale, to prove they were underpaid. However, Jones Day said these women did not deserve to be paid on the scale, claiming the firm’s geographic market and the women’s alleged sub-par performances as its defenses.

 

“Plaintiffs’ pay discrimination claims are based on the misconceived and legally baseless notion that all lawyers in all geographic markets have, at all times over the past decade, been entitled to so-called ‘Cravath scale’ regardless of the quality of their performance or their productivity,” the response said.

 

Jones Day’s defense also called out two of the plaintiffs, saying they “struggled with basic tasks,” “received below-average reviews” and did the “minimum,” and thus were not deserving of Cravath pay.

 

The response takes an unexpected turn when Jones Day says the women’s claim that they endured fraternity culture positioned women as “weak, powerless, and incapable of making their own choices or taking responsibility for their own actions,” and thus was “offensive” in its own right.

 

The lawsuit cited senior male partners mentoring sometimes less-qualified young male associates, giving them preferential treatment and grooming them for leadership as an example of this “fraternity culture.”

 

These kind of gendered inequalities in mentorship and treatment are real — and common — issues for women in corporate America. The recently-released 2018 Women in the Workplace report by LeanIn.org and McKinzey & Company highlights that overall, women report receiving less support from higher-ups than their male counterparts. One respondent of the report said she observed men tend to be “hand-held” through their careers and “groomed” for success, whereas women have to work harder for recognition.

 

Another claim Jones Day made that puzzled journalists who had experience reporting on the company was that their compensation system isn’t a “black box,” meaning they publish information on its compensation and evaluation processes online and internally.

 

An earlier, eventually dropped, gender discrimination lawsuit against the company accused its compensatory policies as being part of a “black box.”

 

The complaint the women filed seeks $200 million in damages.

Latest News

What Friends Tell Friends: Choose Kaiser Permanente

Originally published on about.kaiserpermanente.org. Integrated, nonprofit health plan tops NICE Satmetrix customer experience benchmark study for 10th straight year. For the 10th year in a row, more people would recommend Kaiser Permanente to a friend or colleague than any other health plan in the nation, according to the recently released…

Cesar Conde

NBCUniversal Sets Ambitious 50% Diversity Goal for Women, People of Color

Cesar Conde, chairman at NBCUniversal News Group, announced a groundbreaking goal to have a 50% diverse workforce at NBCUniversal, according to Deadline. Conde, the first Latino in this role, outlined his plans in an internal video for employees on Wednesday. The ultimate goal is for NBCUniversal, No. 7 on DiversityInc’s 2020…

Mastercard Expands ShopOpenings.com to the U.S. & Canada, Delivering a Search Tool That Identifies What Stores Near You Are Open for Business

Originally published on mastercardcontentexchange.com. Search solution complements new Digital Acceleration for Small Business global initiative which helps small businesses advance digitally and drive online commerce As businesses seek to draw customers back both in store and online, Mastercard is introducing new tools to support them. Today, Mastercard announced the geographic…

TIAA Launches Programs to Raise Awareness of Racial Injustice and Support Communities in Need through the “Be The Change” Initiative

On June 30, TIAA announced new virtual programs designed to raise awareness of racial injustice and support communities in need as a part of the company’s recently launched “Be the Change” initiative. One is TIAA’s “Race Against Racism,” an effort in support of The Innocence Project which included more than…

Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries

Originally published on jnj.com. Joint efforts aim to accelerate scale-up of WHO-recommended all-oral treatment regimens – a transition urgently needed to help protect the health of people with drug resistant-tuberculosis who are particularly vulnerable during COVID-19 pandemic In 2020, the initiative aims to reach at least 125,000 patients and could…

Toyota, Alabama A&M and Huntsville Hospital Collaborate to Make COVID-19 Testing Easier

Originally published on pressroom.toyota.com. $100,000 grant provides free service to the community Alabama A & M University (AAMU), Huntsville Hospital and Toyota are developing a mobile health clinic initiative to provide free COVID-19 testing to underserved communities in Madison County. Launching later this year, the mobile medical clinic program has…

Sanofi and Regeneron Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients

Originally published on sanofi.com. Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Phase 3 trial of Kevzara® (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints when Kevzara was added to best supportive care compared to best supportive care alone (placebo)….